missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Tocris Bioscience™ GSK 2606414
Klicka för att se tillgängliga alternativ
Kvantitet:
10 mg
50 mg
Description
GSK 2606414 is a potent and selective protein kinase R-like ER kinase (PERK) inhibitor (IC50 = 0.4 nM). Exhibits >1000-fold selectivity for PERK over HR1 and PKR. Inhibits thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells. Attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Orally bioavailable.
Specifications
Specifications
| Kvantitet | 10 mg |
| Produkttyp | GSK 2606414 |
| Renhet | >99% |
| Molekylvikt (g/mol) | 451.44 |
| Inhibitorer | GSK 2606414 |
For Research Use Only
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction